{Reference Type}: Journal Article
{Title}: Cephalosporin Allergy: Updates on Diagnostic Testing.
{Author}: Chow TG;Brunner ES;Khan DA;
{Journal}: Curr Allergy Asthma Rep
{Volume}: 24
{Issue}: 10
{Year}: 2024 Oct 14
{Factor}: 4.919
{DOI}: 10.1007/s11882-024-01171-9
{Abstract}: OBJECTIVE: Cephalosporins are one of the most prescribed antibiotics worldwide and are implicated in a wide range of hypersensitivity reactions (HSR). This review summarizes recent updates in cephalosporin hypersensitivity with a focus on diagnostic testing.
RESULTS: Reported testing strategies to evaluate different immediate and delayed cephalosporin HSR have included skin testing, in vitro testing, and diagnostic drug challenges. However, the diagnostic performance of in vivo and in vitro tests remains unclear across different hypersensitivity endotypes; adequately powered studies investigating the true positive and negative predictive value of these diagnostic modalities are needed using the reference standard of drug challenges to define cephalosporin hypersensitivity. Refinement of diagnostic testing should be guided by growth in our understanding of cephalosporin antigenic determinants. This growth will be crucial in driving further clarification of cross-reactivity between cephalosporins, and potentially delineating streamlined evaluation processes resulting in reduced unnecessary antibiotic avoidance.